Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein
Tomaz B. Manzoni(University of Pennsylvania), Paul Bates(University of Pennsylvania)
Cited by 7
Related Papers
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
|Proceedings of the National Academy of Sciences|2004|572
Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein
|PLoS Pathogens|2010|145
Comparison of Vaccine Platforms for Machupo Virus
|Vaccines|2026|0